Literature DB >> 8625576

Total knee arthroplasty in tuberculous arthritis.

J Y Su1, T L Huang, S Y Lin.   

Abstract

Sixteen cases of tuberculosis of the knee treated by total knee arthroplasty with followup of 3.4 to 11 years were reviewed. Eight cases were treated with antituberculous chemotherapy for 2 to 20 months before and 1 year after the arthroplasty. Another 8 cases were not diagnosed primarily and therefore received only postoperative antituberculous chemotherapy. Five cases had a recurrence of tuberculosis. Four of these 5 cases did not receive preoperative antituberculous treatment. The infection in 1 case was controlled satisfactorily with chemotherapy alone, and for the other 3 cases, chemotherapy was supported by surgical debridements. The last case of recurrent infection occurred in a patient who had received long- standing corticosteroid therapy. He required an excisional arthroplasty to control the infection. The mean functional knee score was 30.5 points before surgery and 82.6 points at the time of the last followup. These results suggest that arthroplasty may be formed for knees badly damaged with tuberculous infection, and good results may be expected for those patients who have received effective antituberculous chemotherapy both before and after surgery. There is a substantial risk of reactivation of tuberculous infection for those patients not treated before surgery or for patients dependent on corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625576     DOI: 10.1097/00003086-199602000-00024

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Total hip replacement for arthritis following tuberculosis of hip.

Authors:  Vijay Kumar; Bhavuk Garg; Rajesh Malhotra
Journal:  World J Orthop       Date:  2015-09-18

2.  How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?

Authors:  Jae Hoo Lee; Chang Dong Han; Sang-Nae Cho; Ick Hwan Yang; Woo Suk Lee; Seung-Hun Baek; Jae Won Shin; Khalid Elfadil Ibrahim Husein; Kwan Kyu Park
Journal:  Clin Orthop Relat Res       Date:  2017-08-09       Impact factor: 4.176

3.  Total knee arthroplasty in advanced tuberculous arthritis of the knee.

Authors:  Min Zeng; Jie Xie; Long Wang; Yihe Hu
Journal:  Int Orthop       Date:  2015-11-18       Impact factor: 3.075

4.  Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study.

Authors:  Chang Dong Han; Taegwon Oh; Sang-Nae Cho; Jae Ho Yang; Kwan Kyu Park
Journal:  Clin Orthop Relat Res       Date:  2013-03-16       Impact factor: 4.176

Review 5.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  Total knee arthroplasty for the management of joint destruction in tuberculous arthritis.

Authors:  Yusuf Oztürkmen; Onat Uzümcügil; Mahmut Karamehmetoğlu; Cem Leblebici; Mustafa Caniklioğlu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-21       Impact factor: 4.342

7.  Mycobacterium Tuberculosis Monoarthritis of the Knee in Children: A Case Report.

Authors:  Christopher N Carender; Craig Chike Akoh; Heather R Kowalski
Journal:  Iowa Orthop J       Date:  2018

8.  Tuberculosis of the knee: A pitfalls in clinical settings (A case report and literature review).

Authors:  Noni Novisari Soeroso; Fannie Rizki Ananda; Heru Rahmadhany; Dedy Dwi Putra
Journal:  Int J Surg Case Rep       Date:  2020-05-12

9.  Current concepts in the diagnosis and management of tuberculosis of the elbow joint.

Authors:  Gaurav Kumar Upadhyaya; Amit Kumar; Karthikeyan P Iyengar; Anil Agarwal; Vijay Kumar Jain
Journal:  J Clin Orthop Trauma       Date:  2021-05-24

10.  Knee arthrodesis using a unilateral external fixator combined with crossed cannulated screws for the treatment of end-stage tuberculosis of the knee.

Authors:  Xin Tang; Jing Zhu; Qi Li; Gang Chen; Weili Fu; Jian Li
Journal:  BMC Musculoskelet Disord       Date:  2015-08-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.